Rubin Steven D 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Rubin Steven D
Director
Transactions
- Award
Restricted Stock Units
2024-01-24+7,500→ 7,500 total→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.